Published in BMC Cancer on July 08, 2016
Checkpoint Proteins in Pediatric Brain and Extracranial Solid Tumors: Opportunities for Immunotherapy. Clin Cancer Res (2016) 0.77
Immunotherapies in sarcoma: Updates and future perspectives. World J Clin Oncol (2017) 0.75
PDL1 expression is a poor-prognosis factor in soft-tissue sarcomas. Oncoimmunology (2017) 0.75
Targeting the PD-1 pathway in pediatric solid tumors and brain tumors. Onco Targets Ther (2017) 0.75
PD-L1 Expression Is Associated with FOXP3+ Regulatory T-Cell Infiltration of Soft Tissue Sarcoma and Poor Patient Prognosis. J Cancer (2017) 0.75
Treatment of advanced, metastatic soft tissue sarcoma: latest evidence and clinical considerations. Ther Adv Med Oncol (2017) 0.75
Prognostic value of programmed death-ligand 1 in sarcoma: a meta-analysis. Oncotarget (2017) 0.75
Global cancer statistics, 2012. CA Cancer J Clin (2015) 53.52
Ipilimumab plus dacarbazine for previously untreated metastatic melanoma. N Engl J Med (2011) 26.90
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients. Nature (2014) 12.00
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer. N Engl J Med (2015) 11.98
Nivolumab in previously untreated melanoma without BRAF mutation. N Engl J Med (2014) 10.38
Soft-tissue sarcomas in adults. N Engl J Med (2005) 5.97
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial. Lancet (2015) 5.42
Clinical significance of programmed death-1 ligand-1 and programmed death-1 ligand-2 expression in human esophageal cancer. Clin Cancer Res (2005) 4.42
The treatment of malignant tumors by repeated inoculations of erysipelas. With a report of ten original cases. 1893. Clin Orthop Relat Res (1991) 3.79
PD-1 is expressed by tumor-infiltrating immune cells and is associated with poor outcome for patients with renal cell carcinoma. Clin Cancer Res (2007) 3.23
High expression of PD-L1 in lung cancer may contribute to poor prognosis and tumor cells immune escape through suppressing tumor infiltrating dendritic cells maturation. Med Oncol (2010) 3.06
Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial. Lancet Oncol (2014) 2.91
In situ tumor PD-L1 mRNA expression is associated with increased TILs and better outcome in breast carcinomas. Clin Cancer Res (2014) 2.68
Clinical significance of programmed death-1 ligand-1 expression in patients with non-small cell lung cancer: a 5-year-follow-up study. Tumori (2012) 2.55
II. Contribution to the Knowledge of Sarcoma. Ann Surg (1891) 2.21
12-Chemokine gene signature identifies lymph node-like structures in melanoma: potential for patient selection for immunotherapy? Sci Rep (2012) 1.81
Prognostic implications of immunosuppressive protein expression in tumors as well as immune cell infiltration within the tumor microenvironment in gastric cancer. Gastric Cancer (2014) 1.22
PD-L1 expression in melanoma shows marked heterogeneity within and between patients: implications for anti-PD-1/PD-L1 clinical trials. Pigment Cell Melanoma Res (2014) 1.22
Impact of NRAS mutations for patients with advanced melanoma treated with immune therapies. Cancer Immunol Res (2015) 1.20
Prognostic significance of complete surgical resection of pulmonary metastases in patients with osteogenic sarcoma: analysis of 32 patients. J Clin Oncol (1984) 1.03
B7-H1/PD-1 blockade therapy in non-small cell lung cancer: current status and future direction. Cancer J (2014) 1.00
A Pilot Study of Anti-CTLA4 Antibody Ipilimumab in Patients with Synovial Sarcoma. Sarcoma (2013) 0.98
SYT-SSX breakpoint peptide vaccines in patients with synovial sarcoma: a study from the Japanese Musculoskeletal Oncology Group. Cancer Sci (2012) 0.94
[WHO classification of tumours of soft tissue and bone 2013: the main changes compared to the 3rd edition]. Cesk Patol (2014) 0.93
Inhaled granulocyte-macrophage colony stimulating factor for first pulmonary recurrence of osteosarcoma: effects on disease-free survival and immunomodulation. a report from the Children's Oncology Group. Clin Cancer Res (2010) 0.87
The role of the polycomb repressive complex pathway in T and NK cell lymphoma: biological and prognostic implications. Tumour Biol (2015) 0.83
Immunotherapeutic approaches to sarcoma. Semin Surg Oncol (1999) 0.82
Regulation of hepatocyte engraftment and proliferation after cytotoxic drug-induced perturbation of the rat liver. Transplantation (2005) 0.88
Practical guidelines for the surgical treatment of gallbladder cancer. J Korean Med Sci (2014) 0.85
β-Catenin activated hepatocellular adenoma: a report of three cases in Korea. Gut Liver (2014) 0.84
Primary omental yolk sac tumor. Obstet Gynecol Sci (2013) 0.84
Is the recent WHO histological classification for gastric cancer helpful for application to endoscopic resection? Gastric Cancer (2015) 0.84
Prediction of biochemical recurrence after radical prostatectomy with PI-RADS version 2 in prostate cancers: initial results. Eur Radiol (2015) 0.83
Growth Patterns of Signet Ring Cell Carcinoma of the Stomach for Endoscopic Resection. Gut Liver (2015) 0.82
NOVA1 inhibition by miR-146b-5p in the remnant tissue microenvironment defines occult residual disease after gastric cancer removal. Oncotarget (2016) 0.81
Leiomyosarcoma: investigation of prognostic factors for risk-stratification model. Int J Clin Oncol (2015) 0.81
Usefulness of Immunohistochemistry for Microsatellite Instability Screening in Gastric Cancer. Gut Liver (2015) 0.81
PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor for head and neck cancer patients. Sci Rep (2016) 0.80
Endoscopy-guided balloon dilation of benign anastomotic strictures after radical gastrectomy for gastric cancer. Gut Liver (2014) 0.79
Long-term outcome after liver resection and clinicopathological features in patients with small hepatocellular carcinoma. Korean J Hepatobiliary Pancreat Surg (2011) 0.78
MicroRNA alteration and putative target genes in high-grade prostatic intraepithelial neoplasia and prostate cancer: STAT3 and ZEB1 are upregulated during prostate carcinogenesis. Prostate (2016) 0.77
Does Radiotherapy for the Primary Tumor Benefit Prostate Cancer Patients with Distant Metastasis at Initial Diagnosis? PLoS One (2016) 0.77
Poorly Differentiated Carcinoma Component in Submucosal Layer Should be Considered as an Additional Criterion for Curative Endoscopic Resection of Early Gastric Cancer. Ann Surg Oncol (2015) 0.76
Upregulated Neuro-oncological Ventral Antigen 1 (NOVA1) Expression Is Specific to Mature and Immature T- and NK-Cell Lymphomas. J Pathol Transl Med (2016) 0.76
Non-contrast magnetic resonance imaging for bladder cancer: fused high b value diffusion-weighted imaging and T2-weighted imaging helps evaluate depth of invasion. Eur Radiol (2017) 0.76
Reassessment of alkaline phosphatase as serum tumor marker with high specificity in osteosarcoma. Cancer Med (2017) 0.75
Mucinous Carcinoma with Extensive Signet Ring Cell Differentiation: A Case Report. J Pathol Transl Med (2016) 0.75
The Implications of Endoscopic Ulcer in Early Gastric Cancer: Can We Predict Clinical Behaviors from Endoscopy? PLoS One (2016) 0.75
Oncologic Safety of Laparoscopic Wedge Resection with Gastrotomy for Gastric Gastrointestinal Stromal Tumor: Comparison with Conventional Laparoscopic Wedge Resection. J Gastric Cancer (2015) 0.75
HPV vaccine, is it really harmful? J Korean Med Sci (2014) 0.75
Preventive vaccination against cervical cancer: Korean Society of Gynecologic Oncology Guideline. J Gynecol Oncol (2016) 0.75
Incidence and Survival of Pediatric Soft Tissue Sarcomas: Comparison between Adults and Children. Cancer Res Treat (2014) 0.75
Aggressive surgical resection for concomitant liver and lung metastasis in colorectal cancer. Korean J Hepatobiliary Pancreat Surg (2016) 0.75
The Effect of Tumor-Prostate Ratio on Biochemical Recurrence after Radical Prostatectomy. World J Mens Health (2016) 0.75
Alteration status and prognostic value of MET in head and neck squamous cell carcinoma. J Cancer (2016) 0.75
Practice guidelines for management of cervical cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement. J Gynecol Oncol (2017) 0.75
Soft Tissue Roasi-Dorfman Disease with Features of IgG4-Related Disease in a Patient with a History of Acute Myeloid Leukemia. J Pathol Transl Med (2015) 0.75
Prognostic implications of PIK3CA amplification in curatively resected liposarcoma. Oncotarget (2016) 0.75
Adjuvant radiotherapy outcome of stage I testicular seminoma: a single institution study. Yonsei Med J (2015) 0.75
Different subtypes of epithelioid sarcoma and their clinical implication: long-term multi-institutional experience with a rare sarcoma. APMIS (2017) 0.75
Radiological-pathological correlation study of hepatocellular carcinoma undergoing local chemoradiotherapy and surgery. J Gastroenterol Hepatol (2016) 0.75
Clinical Significance of Four Molecular Subtypes of Gastric Cancer Identified by The Cancer Genome Atlas Project. Clin Cancer Res (2017) 0.75
Architectural patterns of p16 immunohistochemical expression associated with cancer immunity and prognosis of head and neck squamous cell carcinoma. APMIS (2017) 0.75
Postoperative Helicobacter pylori Infection as a Prognostic Factor for Gastric Cancer Patients after Curative Resection. Gut Liver (2017) 0.75
The role of tumor size in surgical decision making after endoscopic resection for early gastric cancer. Surg Endosc (2015) 0.75
Development and Validation of a Six-Gene Recurrence Risk Score Assay for Gastric Cancer. Clin Cancer Res (2016) 0.75
Diffusion-weighted imaging predicts upgrading of Gleason score in biopsy-proven low grade prostate cancers. BJU Int (2016) 0.75